Lipopolysaccharide‐regulated secretion of soluble and vesicle‐based proteins from a panel of colorectal cancer cell lines. Issue 2 (4th May 2021)

• Record Type: Journal Article
• Authors: Garcia de Durango, Cira R.; Monteiro, Madalena N.; Bijnsdorp, Irene V.; Pham, Thang V.; De Wit, Meike; Piersma, Sander Rogier; Knol, Jaco C.; Pérez‐Gordo, Marina; Fijneman, Remond J. A.; Vidal‐Vanaclocha, Fernando; Jimenez, Connie R.
• Is Part Of: Proteomics. Volume 15:Issue 2/3(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-05-04
• Subjects: colorectal cancer -- exosome -- extracellular vesicles -- lipopolysaccharide -- NF‐κB -- secretome; Proteomics -- Periodicals; 572.605
• DOI: 10.1002/prca.201900119
• Languages: English
• ISSNs: 1862-8346

Abstract

Abstract: Purpose: To mimic the perioperative microenvironment where bacterial products get in contact with colorectal cancer (CRC) cells and study its impact on protein release, we exposed six CRC cell lines to lipopolysaccharide (LPS) and investigated the effect on the secretome using in‐depth mass spectrometry‐based proteomics. Experimental design: Cancer cell secretome was harvested in bio‐duplicate after LPS treatment, and separated in EV and soluble secretome (SS) fractions. Gel‐fractionated proteins were analysed by label‐free nano‐liquid chromatography coupled to tandem mass spectrometry. NF‐κB activation, triggered upon LPS treatment, was evaluated. Results: We report a CRC secretome dataset of 5601 proteins. Comparison of all LPS‐treated cells with controls revealed 37 proteins with altered abundance in the SS, including RPS25; and 13 in EVs, including HMGB1. Comparing controls and LPS‐treated samples per cell line, revealed 564 significant differential proteins with fold‐change >3. The LPS‐induced release of RPS25 was validated by western blot. Conclusions and clinical relevance: Bacterial endotoxin has minor impact on the global CRC cell line secretome, yet it may alter protein release in a cell line‐specific manner. This modulation might play a role in orchestrating the development of a permissive environment for CRC liver metastasis, especially through EV‐communication.